NLRP3 and hyperparathyroidism: Here, we find that lack of NLRP3 abrogates in vitro osteoclastogenesis induced by bone particles, and more importantly, attenuates bone loss in mouse models of post-menopausal osteoporosis and hyperparathyroidism.